ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,262Medicare Part D Prescriptions Filled, Including Refills

Rank: 124 out of 680

$894K Total Retail Price of All Prescriptions

Rank: 108 out of 680

458 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 458 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 13,209 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LISINOPRIL 531 501 1 5
AMLODIPINE BESYLATE 476 440 2 1
LEVOTHYROXINE SODIUM 458 431 3 2
FUROSEMIDE 394 369 4 6
SIMVASTATIN 360 349 5 3
SERTRALINE HCL 300 280 6 28
ATORVASTATIN CALCIUM 295 244 7 11
OMEPRAZOLE 292 279 8 7
PRAVASTATIN SODIUM 272 253 9 10
NEXIUM 218 208 10 16
TRAMADOL HCL 208 203 11 18
DONEPEZIL HCL 203 203 12 27
NAMENDA 202 202 13 35
ZOLPIDEM TARTRATE 197 187 14 17
GABAPENTIN 196 192 15 15
CITALOPRAM HBR 196 187 15 22
METOPROLOL TARTRATE 186 182 17 12
CYMBALTA 184 149 18 46
HYDROCHLOROTHIAZIDE 182 178 19 9
JANUVIA 181 167 20 60
MEGESTROL ACETATE 179 160 R 21 88
METFORMIN HCL 177 167 22 8
LANTUS 163 142 23 49
HYDROCODONE-ACETAMINOPHEN 145 130 S3 24 4
ALENDRONATE SODIUM 141 111 25 32
CARVEDILOL 138 122 26 23
LOSARTAN POTASSIUM 134 134 27 21
POLYETHYLENE GLYCOL 3350 130 114 28 62
GLIPIZIDE 128 123 29 63
RISPERIDONE 125 107 30 80
MELOXICAM 124 119 31 24
DIOVAN 124 118 31 31
ADVAIR DISKUS 121 94 33 53
PREDNISONE 115 105 34 50
KLOR-CON M20 115 99 34 61
FLUTICASONE PROPIONATE 115 109 34 41
TRAZODONE HCL 104 100 37 48
METOPROLOL SUCCINATE 103 94 38 13
ROPINIROLE HCL 97 97 39 99
TAMSULOSIN HCL 96 76 40 34
CIPROFLOXACIN HCL 91 89 41 57
POTASSIUM CHLORIDE 87 86 42 14
ATENOLOL 87 63 42 19
JANTOVEN 85 85 44 147
BENICAR 85 84 44 131
CLONIDINE HCL 85 76 44 36
PANTOPRAZOLE SODIUM 84 84 47 30
ESCITALOPRAM OXALATE 83 76 48 45
OXYBUTYNIN CHLORIDE 83 70 48 129
LYRICA 83 60 48 77
HUMALOG 83 82 48 196
MIRTAZAPINE 83 79 48 78
BENAZEPRIL HCL 79 79 53 40
CLOPIDOGREL 74 68 54 26
ONGLYZA 70 70 55 136
LEVOFLOXACIN 67 61 56 97
PLAVIX 66 66 57 39
METFORMIN HCL ER 66 66 57 54
EXELON 65 65 59 112
ALBUTEROL SULFATE 64 62 60 154
HUMULIN R 63 63 61 195
DILTIAZEM 24HR ER 59 59 62 132
DIGOXIN 59 59 62 58
SPIRIVA 57 57 64 70
CYCLOBENZAPRINE HCL 56 55 R 65 81
NITROFURANTOIN MONO-MACRO 55 41 66 172
LEVETIRACETAM 55 53 66 120
PHENYTOIN SODIUM EXTENDED 55 38 66 115
WARFARIN SODIUM 54 54 69 20
QUINAPRIL HCL 54 47 69 104
LIPITOR 54 43 69 68
LABETALOL HCL 52 52 72 158
DIVALPROEX SODIUM ER 52 48 72 148
ISOSORBIDE MONONITRATE ER 52 52 72 59
TRAMADOL HCL-ACETAMINOPHEN 52 52 72 153
FINASTERIDE 51 51 76 109
CARBIDOPA-LEVODOPA 50 50 77 117
AZITHROMYCIN 50 46 77 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.